Literature DB >> 27908920

Extreme Insulin Resistance From Insulin Antibodies (Not Insulin Receptor Antibodies) Successfully Treated With Combination Immunosuppressive Therapy.

Jennifer B Hao1, Shahnawaz Imam1, Pervaiz Dar1, Maria Alfonso-Jaume1, Noha Elnagar1, Juan Carlos Jaume2.   

Abstract

Entities:  

Year:  2016        PMID： 27908920     DOI： 10.2337/dc16-1975

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  3 in total

1.  Paradigm shift in the management of type B insulin resistance.

Authors:  Jun Hwa Hong; Hyun Jin Kim; Kang Seo Park; Bon Jeong Ku
Journal:  Ann Transl Med       Date:  2018-12

Review 2.  Hyperinsulinemia Associated Depression.

Authors:  Haider Sarwar; Shafiya Imtiaz Rafiqi; Showkat Ahmad; Sruthi Jinna; Sawleha Arshi Khan; Tamanna Karim; Omar Qureshi; Zeeshan A Zahid; Jon D Elhai; Jason C Levine; Shazia J Naqvi; Juan C Jaume; Shahnawaz Imam
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2022-04-21

3.  Mycophenolate Mofetil and Plasmapheresis: A Treatment Option for Severe Insulin Resistance caused by Insulin Antibodies.

Authors:  Danielle Brooks; Priya Grewal; Ian Baine; Suzanne A Arinsburg; Samir Maximos; Nirali A Shah
Journal:  AACE Clin Case Rep       Date:  2021-03-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.